Shan‐Chao Zhao

3.0k total citations · 1 hit paper
85 papers, 1.5k citations indexed

About

Shan‐Chao Zhao is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Shan‐Chao Zhao has authored 85 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 24 papers in Pulmonary and Respiratory Medicine and 17 papers in Cancer Research. Recurrent topics in Shan‐Chao Zhao's work include Prostate Cancer Treatment and Research (17 papers), Cancer-related gene regulation (11 papers) and Advanced Glycation End Products research (7 papers). Shan‐Chao Zhao is often cited by papers focused on Prostate Cancer Treatment and Research (17 papers), Cancer-related gene regulation (11 papers) and Advanced Glycation End Products research (7 papers). Shan‐Chao Zhao collaborates with scholars based in China, United States and Hong Kong. Shan‐Chao Zhao's co-authors include Xian‐Lu Song, Yu‐Zhong Yu, Daojun Lv, Chong Wang, Zhe‐Sheng Chen, Fangpeng Shu, Mingkun Chen, Yong‐Jie Lu, Jiming Bao and Xinan Li and has published in prestigious journals such as Nature Communications, Biomaterials and Frontiers in Immunology.

In The Last Decade

Shan‐Chao Zhao

78 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Current therapy and drug resistance in metastatic castration-resistant prostate cancer

2023 146 citations Xian‐Lu Song, Mingkun Chen et al. Drug Resistance Updates profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shan‐Chao Zhao China	22	881	435	276	205	166	85	1.5k
Xuejian Zhao China	25	868 1.0×	233 0.5×	307 1.1×	408 2.0×	259 1.6×	62	1.7k
Donita C. Brady United States	25	1.3k 1.5×	383 0.9×	478 1.7×	723 3.5×	151 0.9×	39	2.7k
Frances L. Byrne Australia	22	1.2k 1.4×	603 1.4×	87 0.3×	166 0.8×	117 0.7×	53	1.9k
Sejal Vyas United States	7	1.3k 1.5×	563 1.3×	103 0.4×	425 2.1×	162 1.0×	9	1.9k
Ian R. Corbin United States	23	685 0.8×	434 1.0×	307 1.1×	123 0.6×	379 2.3×	54	1.8k
Ashley Solmonson United States	12	1.8k 2.0×	1.3k 3.0×	334 1.2×	424 2.1×	177 1.1×	18	2.8k
Samuel D. Bernal United States	21	1.2k 1.3×	310 0.7×	329 1.2×	480 2.3×	178 1.1×	51	2.1k
Yoichiro Yoshida Japan	18	881 1.0×	246 0.6×	146 0.5×	581 2.8×	88 0.5×	94	1.7k
Francisco Javier Rodrı́guez-Berrocal Spain	22	677 0.8×	203 0.5×	203 0.7×	442 2.2×	63 0.4×	61	1.4k
Marina Bayeva United States	16	830 0.9×	174 0.4×	257 0.9×	292 1.4×	62 0.4×	18	1.8k

Countries citing papers authored by Shan‐Chao Zhao

Since Specialization

Citations

This map shows the geographic impact of Shan‐Chao Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shan‐Chao Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shan‐Chao Zhao more than expected).

Fields of papers citing papers by Shan‐Chao Zhao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shan‐Chao Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shan‐Chao Zhao. The network helps show where Shan‐Chao Zhao may publish in the future.

Co-authorship network of co-authors of Shan‐Chao Zhao

This figure shows the co-authorship network connecting the top 25 collaborators of Shan‐Chao Zhao. A scholar is included among the top collaborators of Shan‐Chao Zhao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shan‐Chao Zhao. Shan‐Chao Zhao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tang, Yu-Ting, Yu‐Zhong Yu, Tao Xie, et al.. (2025). TGFβ-activated Asporin interacts with STMN1 to promote prostate cancer docetaxel chemoresistance and metastasis by upregulating the Wnt/β-catenin signaling pathway. Drug Resistance Updates. 81. 101227–101227. 2 indexed citations

Guo, JinYu, Hui Yang, Di Cui, et al.. (2025). BOOST: a robust ten-fold expansion method on hour-scale. Nature Communications. 16(1). 2107–2107. 1 indexed citations

Wang, Zifan, Shan‐Chao Zhao, Meixin Zhu, et al.. (2025). Preference Aligned Diffusion Planner for Quadrupedal Locomotion Control. 15888–15894.

Zheng, Liuhai, Guangwei Shi, Yang Li, et al.. (2025). CDH17-targeting CAR-NK cells synergize with CD47 blockade for potent suppression of gastrointestinal cancers. Acta Pharmaceutica Sinica B. 15(5). 2559–2574. 2 indexed citations

Chen, Yao, Yongcheng Ren, Mingkun Chen, et al.. (2025). Tegaserod maleate exerts anti-tumor effects on prostate cancer via repressing sonic hedgehog signaling pathway. Molecular Medicine. 31(1). 30–30.

Li, Menglu, Qi Sun, Yuwei Zhang, et al.. (2025). Probiotic domestication and engineering enable one-shot treatment for bladder mucosal repair. Biomaterials. 318. 123123–123123. 2 indexed citations

Yu, Yu‐Zhong, Xiao Xie, Yongcheng Ren, et al.. (2025). Identification of pyrimidine metabolism-based molecular subtypes and prognostic signature to predict immune landscape and guide clinical treatment in prostate cancer. Annals of Medicine. 57(1). 2449584–2449584.

Yu, Yu‐Zhong, Daojun Lv, Tao Xie, et al.. (2024). NAT10 Promotes Prostate Cancer Growth and Metastasis by Acetylating mRNAs of HMGA1 and KRT8. Advanced Science. 11(32). e2310131–e2310131. 23 indexed citations

Zhao, Shan‐Chao, Xinjun Zheng, Lihe Yin, & Yugang Wang. (2023). Forest stand factors determine the rainfall pattern of crown allocation of Picea schrenkiana in the northern slope of Mount Bogda, Tianshan Range, China. Frontiers in Plant Science. 13. 1113354–1113354. 4 indexed citations

10.

Liu, Pengyu, Wenxuan Wang, Fei Wang, et al.. (2023). Alterations of plasma exosomal proteins and motabolies are associated with the progression of castration-resistant prostate cancer. Journal of Translational Medicine. 21(1). 40–40. 32 indexed citations

11.

Wang, Chong, Tao Wang, Yue Li, et al.. (2023). SETD4 inhibits prostate cancer development by promoting H3K27me3-mediated NUPR1 transcriptional repression and cell cycle arrest. Cancer Letters. 579. 216464–216464. 9 indexed citations

12.

Yu, Yu‐Zhong, Daojun Lv, Chong Wang, et al.. (2022). Hsa_circ_0003258 promotes prostate cancer metastasis by complexing with IGF2BP3 and sponging miR-653-5p. Molecular Cancer. 21(1). 12–12. 108 indexed citations

13.

Xie, Tao, Zhimin Li, Daojun Lv, et al.. (2022). CircSMARCC1 facilitates tumor progression by disrupting the crosstalk between prostate cancer cells and tumor-associated macrophages via miR-1322/CCL20/CCR6 signaling. Molecular Cancer. 21(1). 173–173. 68 indexed citations

14.

Zhang, Wei, Siyu Xia, Wei Xiao, et al.. (2022). A single-cell transcriptomic landscape of mouse testicular aging. Journal of Advanced Research. 53. 219–234. 49 indexed citations

15.

Yao, Bing, Sha Zhu, Mingkun Chen, et al.. (2022). The circSPON2/miR-331-3p axis regulates PRMT5, an epigenetic regulator of CAMK2N1 transcription and prostate cancer progression. Molecular Cancer. 21(1). 119–119. 33 indexed citations

16.

Xie, Tao, Xian‐Lu Song, Chong Wang, et al.. (2021). The role of androgen therapy in prostate cancer: from testosterone replacement therapy to bipolar androgen therapy. Drug Discovery Today. 26(5). 1293–1301. 9 indexed citations

17.

Zhou, Jiawei, Yunhua Mao, Yunlin Ye, et al.. (2021). A novel robust nomogram based on peripheral monocyte counts for predicting lymph node metastasis of prostate cancer. Asian Journal of Andrology. 23(4). 409–414. 3 indexed citations

18.

Shu, Fangpeng, Daojun Lv, Xian‐Lu Song, et al.. (2018). Fabrication of a hyaluronic acid conjugated metal organic framework for targeted drug delivery and magnetic resonance imaging. RSC Advances. 8(12). 6581–6589. 88 indexed citations

19.

Chen, Zhuangfei, Zehai Huang, Tong Chen, et al.. (2017). [Quantitative and comparative proteomics analysis in clear cell renal cell carcinoma and adjacent noncancerous tissues by 2-D DIGE].. Europe PMC (PubMed Central). 37(11). 1517–1522. 2 indexed citations

20.

Zhao, Shan‐Chao, Qing Chen, Jiming Bao, et al.. (2014). Association between FOXO3A gene polymorphisms and human longevity: a meta-analysis. Asian Journal of Andrology. 16(3). 446–446. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact